• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Carpio Fernando

    3/18/26 8:05:33 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Carpio Fernando

    (Last)(First)(Middle)
    6, RUE JEAN MONNET

    (Street)
    LUXEMBOURGGRAND DUCHY OF LUXEMBOURGL-2180

    (City)(State)(Zip)

    LUXEMBOURG

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/18/2026
    3. Issuer Name and Ticker or Trading Symbol
    AUNA S.A. [ AUNA ]
    3a. Foreign Trading Symbol
    [AUNA]
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    Internal Auditor
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Class A Common Shares4,782(1)D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Share Option (right to buy) (2)03/21/2029Class A Common Shares15,000$12D
    Share Option (right to buy) (3)07/11/2035Class A Common Shares18,000$6.32D
    Explanation of Responses:
    1. Includes 3,283 common shares underlying outstanding restricted share units.
    2. This share option will vest annually in four equal installments beginning on March 21, 2025.
    3. This share option will vest annually in four equal installments beginning on July 11, 2026.
    Remarks:
    Exhibit 24 - Power of Attorney
    /s/ Carolina Brovelli, attorney-in-fact for Fernando Carpio03/18/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $AUNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    1/21/2026$6.90Hold → Buy
    HSBC Securities
    1/16/2026$9.00Buy
    Jefferies
    11/18/2025$6.00Overweight → Neutral
    Analyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Auna S.A. upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Auna S.A. from Hold to Buy and set a new price target of $6.90

    1/21/26 8:29:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Jefferies initiated coverage on Auna S.A. with a new price target

    Jefferies initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $9.00

    1/16/26 8:40:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna S.A. downgraded by Analyst with a new price target

    Analyst downgraded Auna S.A. from Overweight to Neutral and set a new price target of $6.00

    11/18/25 8:17:10 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Auna Announces 4Q25 and FY25 Financial Results

    Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 ("fourth quarter 2025" or "4Q25") and full-year ended 2025 ("full-year 2025" or "FY25"). Financial results are expressed in Peruvian Soles ("S/" or "PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. FY25 Conso

    3/10/26 4:15:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna and EsSalud Finalize Addendum to Commence Construction of Torre Trecca in Lima, Which Will Become Peru's Largest Outpatient Facility

    Auna S.A. ("Auna" or the "Company"), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today announced the formal execution of an addendum to its existing Public-Private Partnership ("PPP") agreement with EsSalud, Peru's Social Health Insurance agency. This agreement facilitates the commencement of the construction phase of the Torre Trecca project in Lima. The execution of the addendum is an important milestone for the project and formally authorizes the commencement of construction of Torre Trecca, a 23-story, high-complexity outpatient healthcare facility. The facility will encompass approximately 59,000 square meters of built area,

    2/26/26 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in

    2/2/26 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Carpio Fernando

    3 - AUNA S.A. (0001799207) (Issuer)

    3/18/26 8:05:33 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Harb Rayet

    3 - AUNA S.A. (0001799207) (Issuer)

    3/18/26 7:58:42 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Remy Gisele

    3 - AUNA S.A. (0001799207) (Issuer)

    3/18/26 7:55:50 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    SEC Filings

    View All

    SEC Form 6-K filed by Auna SA

    6-K - AUNA S.A. (0001799207) (Filer)

    3/10/26 4:17:08 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Auna SA

    6-K - AUNA S.A. (0001799207) (Filer)

    2/26/26 8:37:24 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form SCHEDULE 13G filed by Auna SA

    SCHEDULE 13G - AUNA S.A. (0001799207) (Subject)

    2/13/26 2:52:14 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    View All

    Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

    3/7/25 8:00:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

    12/19/24 9:01:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

    Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

    9/3/24 11:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Financials

    Live finance-specific insights

    View All

    Auna Announces 4Q25 and FY25 Financial Results

    Auna Closes FY 2025 with Strong Performance in Peru and Colombia and 35% increase in Free Cash Flow Signs of Recovery in Mexico in 2026 Company Sets 12% Adjusted EBITDA Growth Guidance for 2026 Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 ("fourth quarter 2025" or "4Q25") and full-year ended 2025 ("full-year 2025" or "FY25"). Financial results are expressed in Peruvian Soles ("S/" or "PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. FY25 Conso

    3/10/26 4:15:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2025 Financial Results

    Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2025 financial results. Earnings Release Tuesday, March 10, 2026 Time: After Market Close Conference Call Wednesday, March 11, 2026 Time: 8:00 a.m. ET Quiet Period Monday, February 23 through Tuesday, March 10, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in

    2/2/26 8:30:00 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Auna Announces 3Q25 Financial Results

    Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the third quarter ended September 30, 2025 ("third quarter 2025" or "3Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q25 Consolidated Highlights Consolidated Revenue increased 1% FXN, while decreasing 1% YoY on reported basis, to S/1,117 million Adjust

    11/20/25 4:45:00 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/14/24 2:22:37 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Auna SA

    SC 13G/A - AUNA S.A. (0001799207) (Subject)

    11/13/24 10:53:24 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by Auna SA

    SC 13G - AUNA S.A. (0001799207) (Subject)

    11/12/24 6:09:04 AM ET
    $AUNA
    Medical/Nursing Services
    Health Care